相关实验视频
Updated: Jul 14, 2026

11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
16.4K
总胰腺切除术后复发性低血糖的风险和长期存活:一项前性观察性研究
Zofia Czarnecka1,2, Kevin Verhoeff1, Alice L J Carr2
1Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
Annals of surgery
|August 12, 2025
概括
全胰腺切除术 (TP) 患者面临的严重低血糖风险比以前认为的要低,这要归功于现代胰岛素和持续血糖监测器 (CGM). 这些进展改善了结果,有助于为TP患者做出手术决策.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 总胰腺切除术 (TP) 历来存在重大风险,包括严重的低血糖症 (SHE),由于荷尔蒙损失.
- 虽然TP与小岛自移植 (TPIAT) 可以保持内分泌功能,但过去的SHE发病率报告高达41%.
- 胰岛素治疗和持续血糖监测 (CGMs) 的近期进展可能已经改善了结果,但需要在TP患者身上进行进一步的研究.
研究的目的:
- 在接受全胰腺切除术 (TP) 的患者中评估严重低血糖症 (SHE) 的风险.
- 评估现代糖尿病管理技术对血糖控制和TP后结果的影响.
- 为了比较单独TP与TP与小岛自移植 (TPIAT) 之间的结果.
主要方法:
- 一项单中心研究分析了147名在2009年至2024年期间接受过TP的患者.
- 使用了连续血糖监测器 (CGM),前提是患者没有一个.
- 收集的数据包括人口统计,生存率,急诊室访问和血糖控制指标.
主要成果:
- 在147个TP病例中 (76个TP单独,71个TPIAT),TP单独组中的2例死亡 (2.63%) 归因于低血糖.
- 与TPIAT患者 (5.9±1.3%) 相比,单独TP的患者 (7.1±2.2%) 的手术前HbA1c更高.
- 在手术后,在CGM监测的14天内,TP单独患者没有观察到严重的低血糖症;长期来看,血糖控制指标在组之间是相似的.
结论:
- 与历史数据相比,现代胰岛素疗法和CGM有助于TP后的可接受结果,SHE风险降低.
- 这些发现表明,在没有补充小岛移植的情况下,可以有效地管理TP.
- 这些数据支持改善手术决策和对TP的患者选择.
相关概念视频
Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

